GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Debt-to-EBITDA

Fractyl Health (Fractyl Health) Debt-to-EBITDA : -1.67 (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Fractyl Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.73 Mil. Fractyl Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $83.66 Mil. Fractyl Health's annualized EBITDA for the quarter that ended in Dec. 2023 was $-51.77 Mil. Fractyl Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -1.67.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Fractyl Health's Debt-to-EBITDA or its related term are showing as below:

GUTS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.23   Med: -0.51   Max: -0.4
Current: -3.23

During the past 5 years, the highest Debt-to-EBITDA Ratio of Fractyl Health was -0.40. The lowest was -3.23. And the median was -0.51.

GUTS's Debt-to-EBITDA is ranked worse than
100% of 276 companies
in the Biotechnology industry
Industry Median: 1.37 vs GUTS: -3.23

Fractyl Health Debt-to-EBITDA Historical Data

The historical data trend for Fractyl Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fractyl Health Debt-to-EBITDA Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
-0.51 -0.54 -0.47 -0.40 -1.71

Fractyl Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.43 N/A -1.01 -1.67

Competitive Comparison of Fractyl Health's Debt-to-EBITDA

For the Biotechnology subindustry, Fractyl Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fractyl Health's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Fractyl Health's Debt-to-EBITDA falls into.



Fractyl Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Fractyl Health's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.731 + 83.66) / -50.55
=-1.71

Fractyl Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.731 + 83.66) / -51.772
=-1.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Fractyl Health  (NAS:GUTS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Fractyl Health Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Fractyl Health's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Fractyl Health (Fractyl Health) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hartwell Avenue, Lexington, MA, USA, 02421
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.